SOCS2 expression in bone marrow derived dendritic cells is a positive regulator of T cell activation by Jin Hu et al.
POSTER PRESENTATION Open Access
SOCS2 expression in bone marrow derived
dendritic cells is a positive regulator of T cell
activation
Jin Hu1*, Berit Carow4, Ann-Charlotte Wikström3, Martin Rottenberg4, Gunnar Norstedt2, Ola Winqvist1
From 7th European Workshop on Immune-Mediated Inflammatory Diseases
Noordwijk aan Zee, the Netherlands. 28-30 November 2012
Background
After a completed T cell response the activation of DCs
needs to be terminated to avoid harmful inflammation or
autoimmune disease. Besides the negative regulation of
JAK/STAT signaling pathway on growth hormone and
prolactin for suppressor of cytokine signaling (SOCS) 2
[1], murine SOCS2-/- DCs are recently found to be hyper-
responsive to microbial stimuli and refractory to the inhi-
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Figure 1 The effect of SOCS2 KO, on pro-inflammatory cytokine release in LPS induced BMDCs. BMDCs from WT and SOCS2 mice were
stimulated with LPS (100 ng/ml) till 48 hours. mRNA expression of indicated cytokines was measured at the indicated time points.
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bitory actions of the anti-inflammatory mediator LXA4
[2]. Thus, we investigate the role of SOCS2 in DC antigen
presentation.
Materials and methods
Mice: SOCS2 deficient mice and transgenic OT-II mice.
Mouse bone marrow-derived dendritic cells (BMDCs):
Mouse bone marrow cells were incubated 7 days with
20 ng/ml GM-CSF and 20 ng/ml IL-4 to create mouse
BMDCs. Quantitative RT-PCR: Real-time PCR was used
to measure pro-inflamatory cytokines gene expression.
CFSE proliferation assay: BMDCs were incubated with
100 ng/ml LPS and 50 ng/ml OVA323-339 peptide. The
next day CD90+ splenocytes from OT-II mice were
labeled with CFSE and added to the BMDC culture for
5 days. Then cells were stained for CD4 and read by
FACS.
Results
Increased production of pro-inflammatory cytokines by
SOCS2-/- BMDCs in response to LPS (see Figure 1)
SOCS-/- BMDCs have a decreased capacity to activate
naïve CD4+ T cells (see Figure 2)
Conclusions
SOCS2 is complex regulator of DC effecter functionality,
with an overall positive regulatory function on T cell
activation.
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Figure 2 Proliferation of CD4+ T antigen specific cells is decreased when co-cultured with SOCS2-/- mice BMDCs The CFSE-labeled OTII
CD4+ T cells were co- cultured with DCs alone, LPS matured DCs, or LPS matured DCs plus OVA from WT and SOCS2 mice, respectively. The
CD4 Tcells were harvested to determine the number of divisions by flow cytometry after 5 days.
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